UCB Pharma PRESENTATION #PLA2020


Business Case : Entering the Digital Era for Environmental Monitoring Data Processing

Abstract

Capturing, analyzing and understanding the dynamics of the huge amount of environmental monitoring data are crucial for the BioPharma industry. Since UCB is following the digital transformation path of laboratory and data processes, Eric De Maesschalck will be presenting how UCB has significantly enhanced its processes. Thanks to advanced analytics tools, the visualization and understanding of environmental monitoring data dynamics is dramatically improving. Quick detection of trends and powerful capabilities to dig into them to understand what is happening, or could happen, is key.

This case study will provide an overview on:

  • The e-transformation journey of environmental monitoring data processing
  • How UCB is jumping from level 1 to level 3-4 in the Digital Maturity Model for EM
  • How a few clicks can replace tens of hours of manual data analysis and provide immediate responses and clear visualization of what is happening.

Dare your company to initiate de digitalization of the laboratory processes and get the best of your data!

Presenter

Eric De Maesschalck Paperless Lab Academy

Name: Eric De Maesschalck

Title: Head Laboratory Digitalization, Corporate  Processes and Operations

UCB Pharma S.A.

Eric graduated in Clinical Chemistry and Medical Biology. He has spent 32 years in highly regulated pharmaceutical companies: GSK, Pfizer, Phibro Animal Health and UCB BioPharma. Eric has 27 years of experience in computerized systems qualification and validation including IT infrastructure (GMP, GCP, GLP, GPvP). Eric’s position at UCB Pharma is Head Laboratory Digitalization, Corporate Processes and Operations where, among other things, he is defining and following the digital transformation path of laboratory analytical and data processes in partnership with laboratory management and IT. Eric is therefore involved in several UCB Digital communities and is involved in all laboratory digital projects.

UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology.

Our business is strong. UCB’s ambition is to transform the lives of people living with severe diseases. We focus on neurology and immunology disorders – putting patients at the center of our world. We are Inspired by Patients. Driven by Science.

Corporate website:https://www.ucb.com/